HOME >> BIOLOGY >> NEWS
Landmark FSU study of hepatitis C virus solves mystery that has stymied quest for cure

The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for experimental research.

Now, in a landmark study by Florida State University biologists that could bolster the development of anti-viral therapies for HCV as well as for related RNA viruses such as West Nile and influenza Assistant Professor Hengli Tang and doctoral student/co-author Heather B. Nelson have discovered the molecular mechanism that inhibits HCV replication in vitro after its host cells become crowded and stopped dividing.

What's more, their groundbreaking discovery came about as a result of the new test they developed that can quickly and easily monitor HCV replication in the laboratory.

Finally, after Tang and Nelson uncovered the reason for suppression of the virus in cell culture in a nutshell: not enough nucleotide molecules, the building blocks of HCV they then adapted an existing cell technology to remedy the problem right in the test tube.

The Tang-Nelson study and a description of the innovative technologies they devised to enable and track it will appear in the Feb. 8 edition of the Journal of Virology.

"Our findings could prove critical to research on HCV's complex virus-host cell interactions and lead to better, targeted treatments," Tang said.

"Currently, any nucleotide starvation therapies, used primarily to treat cancer, can inhibit replication by depriving viral agents of their molecular building blocks. However, those therapies may impact healthy cells, as well, causing undesired side effects."

In the human liver, the parasitic HCV makes copies of its genetic material by hijacking nucleotide
'"/>

Contact: Hengli Tang
tang@bio.fsu.edu
850-645-2402
Florida State University
7-Feb-2006


Page: 1 2 3

Related biology news :

1. Landmark study details demographic, ecological and genetic spread of rabies in raccoon outbreak
2. Landmark study identifies large number of new proteins implicated in Huntingtons disease
3. Landmark study highlights complex genetic risk factors behind type 2 diabetes
4. Landmark comparative genomics study highlights the importance of junk DNA in higher eukaryotes
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. Clones on task serve greater good, evolutionary study shows
7. Pollution causes 40 percent of deaths worldwide, study finds
8. A study by the MUHC and McGill University opens a new door to understanding cancer
9. New study suggests Concord grape juice may provide protection against breast cancer
10. Preclinical study links gene to brain aneurysm formation
11. In limiting life span, study finds booming bacteria innocent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. , an ... IT solutions for the life sciences industry, is pleased to announce the recent hiring ... of the company’s Seabrook, New Hampshire office. In his new role, Boudreau will ...
(Date:5/30/2020)... ... 29, 2020 , ... eInfochips, a leading provider of product ... EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has been ... been clinically tested versus expert measurements, yielding improved results in precision and consistency. ...
(Date:5/26/2020)... (PRWEB) , ... May 26, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, ... T-cell receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 26, 2020 , ... The Security Industry Association ... strong opposition to the recently introduced bicameral Facial Recognition and Biometric Technology ... federal use of nearly all biometric and related image analytics technologies, incorrectly labeling ...
(Date:6/23/2020)... ... 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical company focused ... an Investigational New Drug application (IND) with the U.S. Food & Drug Administration ... NBTX-001 in patients with panic disorder (PD). , "Adding a PD trial to ...
(Date:6/11/2020)... ... , ... Reducing carbon emissions has been and will continue to be a ... dips, ways to reduce CO2 is something we can’t avoid. , To protect ... being produced today are created from recycled cooking oil or crops. Unfortunately, these sources ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... announced the release of Genedata Screener ® 17.0, the latest version of ... from all in-vitro screening assay technologies. Genedata will host a webinar on June ...
Breaking Biology Technology:
Cached News: